EmbryoNet links statins to FGF-like zebrafish developmental effects
A learned embryo-image classifier flagged statin-treated zebrafish as resembling reduced FGF signaling. Follow-up morphology and pERK measurements supported the developmental-pathway association. The mechanism remains proposed, and the zebrafish assays do not establish effects in human pregnancy or clinical use.
Technology: EmbryoNet deep image classifier
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Embryonic morphology and pathway-associated fluorescence were measured.
- Still unknown: Causal mechanism and human relevance were not established.
- AI role: EmbryoNet deep image classifier supported the stated study; experimental and interpretive work remained with researchers.
Evidence sources: https://www.nature.com/articles/s41592-023-01873-4 · https://pubmed.ncbi.nlm.nih.gov/37156842/ · https://www.nature.com/articles/s41592-023-01873-4.pdf
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 16 Nov 2026. Review scope: Indexed primary publisher experimental Results and PDF passages; primary PubMed date and affiliations. Direct full-text retrieval blocked..
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.